Inhibition of human polymorphonuclear leukocyte chemotaxis by oxygenated sterol compounds.

af Gordon, L I, Bass, J, Yachnin, S
Udgivet 1980

Elements of complex variables.

af Pennisi, L. L., Gordon, L. I., Lasher, S..
Udgivet c1963

Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.

af Gordon, L I, Douglas, S D, Kay, N E, Yamada, O, Osserman, E F, Jacob, H S
Udgivet 1979

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma

af Evens, A. M., Carson, K. R., Kolesar, J., Nabhan, C., Helenowski, I., Islam, N., Jovanovic, B., Barr, P. M., Caimi, P. F., Gregory, S. A., Gordon, L. I.
Udgivet 2013

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma

af Evens, A. M., Carson, K. R., Kolesar, J., Nabhan, C., Helenowski, I., Islam, N., Jovanovic, B., Barr, P. M., Caimi, P. F., Gregory, S. A., Gordon, L. I.
Udgivet i Ann Oncol (2014)

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

af Hong, F., Habermann, T. M., Gordon, L. I., Hochster, H., Gascoyne, R. D., Morrison, V. A., Fisher, R. I., Bartlett, N. L., Stiff, P. J., Cheson, B. D., Crump, M., Horning, S. J., Kahl, B. S.
Udgivet i Ann Oncol (2014)

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for Advanced Hodgkin Lymphoma in the Modern Era

af Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J., Advani, R. H.
Udgivet i Br J Haematol (2015)